Every material Form 8-K Cardio Diagnostics Holdings, Inc. filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Cardio Diagnostics Holdings received written notice from Nasdaq on May 28, 2025, that it has regained compliance with the $1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market. The closing bid price was $1.00 or greater for the 10 consecutive business days from May 13 through May 27, 2025. The notice removes the risk of delisting that had been pending under the extended compliance period ending June 2, 2025.
Nasdaq notice dated May 28, 2025 confirms regained compliance with the minimum bid price rule (Listing Rule 5550(a)(2)).
Compliance is based on closing bid prices of $1.00 or greater from May 13, 2025 through May 27, 2025.
The company had been given until June 2, 2025 to regain compliance, following an initial December 2, 2024 deadline.
The non-compliance notice was first received on June 3, 2024.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Cardio Diagnostics Holdings, Inc. filing is on SEC EDGAR ↗. 8-K briefs of other companies →